Skip to main content
PepStack
Blutwerte · Marker

Renin

Plasma Renin Activity · PRA · Renin

Hormone — StressachseZeitabhängig
Einheit:
ng/mL/hr

Renin test quantifies the enzyme renin, which is involved in the regulation of blood pressure and electrolyte balance.

Reference Ranges

Reference
0.23.3ng/mL/hr
0.2
3.3
LowNormalHigh
Reference
Unit · ng/mL/hr

Reference ranges can vary based on posture and sodium intake; typically measured in a seated position.

Overview

Übersicht

Renin is an enzyme secreted by the kidneys that plays a critical role in the renin-angiotensin-aldosterone system (RAAS), which regulates blood pressure and fluid balance. It acts by converting angiotensinogen, released by the liver, into angiotensin I, which is further converted into angiotensin II, a potent vasoconstrictor. Clinically, renin measurements are crucial for diagnosing conditions like primary hyperaldosteronism, where renin levels are typically suppressed due to excessive aldosterone production. Elevated plasma renin activity is also associated with cardiovascular diseases, as it indicates activation of the RAAS, which can lead to hypertension and increased cardiovascular risk. In the context of athletic performance and biohacking, renin levels can reflect hydration status and electrolyte balance, which are important for endurance and recovery. However, interpreting renin levels requires consideration of various factors such as time of day, posture, and sodium intake, as these can significantly influence renin secretion. Researchers have found that renin levels can vary with circadian rhythms and dietary sodium, making standardized testing conditions essential for accurate assessment.

Klinische Bedeutung

Elevated renin levels may indicate conditions such as renovascular hypertension or heart failure, while low levels are often seen in primary hyperaldosteronism. Both scenarios reflect dysregulation of the RAAS.

Dynamics

Trend Interpretation

Rising Values

Progressively rising renin levels suggest worsening RAAS activation, possibly indicating deteriorating cardiovascular health. Re-test in 4-6 weeks if levels are rising.

Falling Values

Falling renin levels may indicate improved blood pressure control or response to RAAS-targeting therapies.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Renovascular hypertension
  • Congestive heart failure
  • Dehydration
  • Low sodium intake
  • Diuretics usage
Cause

Low Levels

  • Primary hyperaldosteronism
  • Cushing's syndrome
  • High sodium intake
  • Congenital adrenal hyperplasia
  • Beta-blocker usage
Protocol

How to Optimize

Lever

Lifestyle

  • Maintain adequate hydration
  • Manage stress levels
  • Regular physical activity
Lever

Nutrition

  • Moderate sodium intake
  • Increase potassium-rich foods

Note:

Consult a healthcare provider before making significant dietary or lifestyle changes, especially if on medication affecting the RAAS.

Testing Guidelines

Fasting Not Required
🕐Time-Sensitive

Renin levels can vary with circadian rhythms; morning testing is recommended for consistency.

Testing Frequency

Annually for individuals with hypertension or cardiovascular risk factors.

Interfering Factors

  • Recent intense exercise
  • Posture during test
  • Sodium intake

Related Peptides & Hormones

Aldosterone

Correlated with

hormone

Open Research Questions

Current research suggests that the optimal reference ranges and critical thresholds for plasma renin activity remain debated, with a need for extensive comparative studies to establish their relative benefits. Researchers have not yet established the precise role of renin in cardiovascular risk stratification, particularly in the context of new pharmacological treatments targeting the renin-angiotensin-aldosterone system. Unanswered clinical questions include how to effectively utilize renin levels in tailoring perioperative management strategies and addressing confounding factors in various patient populations.

25 Research Publications

323

Total Citations

5

Human/RCT

4.0

Avg. Influence

2024

Latest

Sort
Filter
#01

Diagnosis of nontuberculous mycobacterial infections.

ReviewInfluence7.0
151
This study reviewed laboratory methods for diagnosing nontuberculous mycobacterial infections, focusing on the application of various diagnostic techniques. The findings underscore the complexities and controversies in accurately diagnosing these infections.
View on PubMed
#02

Laboratory challenges in primary aldosteronism screening and diagnosis.

ReviewInfluence6.0
74
This review highlighted the laboratory's role in screening for primary aldosteronism, focusing on the measurement of aldosterone and renin. Researchers noted that the lack of standardized methodologies has hindered diagnosis. New methods have improved the reliability of renin testing, which is crucial for accurate diagnosis.
View on PubMed
#03

Renin as a biomarker of cardiovascular disease in clinical practice.

ReviewInfluence1.0
25
Researchers critically evaluated the role of renin as a biomarker for cardiovascular risk and prognosis. They found that elevated plasma renin activity is associated with increased morbidity and mortality in cardiovascular disease, though its utility in risk stratification remains debated.
View on PubMed
#04

Approaches and Challenges for Biosensors for Acute and Chronic Heart Failure.

Review
13
Researchers discussed the importance of biomarkers, including renin, for diagnosing heart failure. They noted that renin is associated with neurohormonal pathways and emphasized the need for fast, portable biosensors to improve diagnostic processes. The review highlights the potential of biomarkers in enhancing heart failure management.
View on PubMed
#05

Voriconazole-associated salt-losing nephropathy.

Case Report
13
Researchers reported a case of a 74-year-old man with salt-losing nephropathy associated with voriconazole treatment. Elevated plasma renin activity was noted alongside other symptoms, indicating the need for careful monitoring of renal function in patients receiving this medication.
View on PubMed
#06

Clinical features, laboratory findings and treatment of juxtaglomerular cell tumors: a systemic review.

ReviewInfluence2.0
9
Researchers summarized the clinical features and laboratory findings of juxtaglomerular cell tumors, noting that elevated plasma renin activity was a common finding. They reported that surgical intervention often restored normal blood pressure and renin levels in affected patients.
View on PubMed
#07

Potential of soluble (pro)renin receptor in kidney disease: can it go beyond a biomarker?

Review
6
This review explored the role of the soluble (pro)renin receptor in kidney disease. Researchers found that this receptor is involved in renal injury and may mediate inflammatory responses through the renin-angiotensin system. The study suggests that soluble (pro)renin receptor could have implications beyond being a mere biomarker.
View on PubMed
#08

Renin imprinted Poly(methyldopa) for biomarker detection and disease therapy.

In Vitro
6
This study explored a novel dual-functional polymer designed for renin detection and therapy. Researchers found that the engineered polymer demonstrated high sensitivity in detecting renin and effectively reduced blood pressure in animal models, suggesting promising clinical applications.
View on PubMed
#09

Hospitalized Patients With COVID-19 Have Higher Plasma Aldosterone-Renin Ratio and Lower ACE Activity Than Controls.

Human
6
This study investigated the differences in RAAS biomarker levels between hospitalized COVID-19 patients and controls. Researchers found that the aldosterone-renin ratio was significantly higher in COVID-19 patients, while ACE activity was lower at the beginning of hospitalization. These findings suggest that high aldosterone-renin ratio may indicate increased risk for COVID-19 complications.
View on PubMed
#10

The spectrum of plasma renin activity and hypertension diseases: Utility, outlook, and suggestions.

Review
5
This review provided an overview of plasma renin activity as a screening tool for primary aldosteronism and hypertension. Researchers noted significant inconsistencies in measurement methods and emphasized the importance of standardization for reliable clinical applications.
View on PubMed

Clinical Trials (3)

3

Total Trials

234

Total Enrolled

Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure

NCT07259512Phase 4RECRUITING
Sponsor

Evi Liliek Wulandari

Enrollment

80

Started

2025

Primary outcome

Change in Plasma Renin Activity (PRA)

Chronic Kidney DiseaseHeart Failure With Reduced Ejection Fraction (HFrEF)

Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

NCT04752293RECRUITING
Sponsor

Wake Forest University Health Sciences

Enrollment

125

Started

2021

Primary outcome

Baseline Urine Angiotensin-(1-7)/Creatinine Ratio

HypertensionLeft Ventricular HypertrophyLeft Ventricular DysfunctionLeft Atrial DilatationLeft Ventricular Diastolic DysfunctionKidney DiseasesKidney InjuryKidney DysfunctionSodium Urine HighBlood Pressure DisordersUric Acid RetentionAngiotensin HypertensionAutonomic DysfunctionAutonomic ImbalancePediatric Kidney DiseasePediatric ObesityProteinuriaAlbuminuria

Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)

NCT03317925COMPLETED
Sponsor

Wake Forest University Health Sciences

Enrollment

29

Started

2014

Primary outcome

Acute graft injury

Renal TransplantRenin-Angiotensin SystemRejection Acute RenalRejection Chronic RenalRejection of Renal Transplant

Publication Trend

Research publications about Renin over time

8total
1
'02
1
'06
1
'10
1
'12
1
'22
1
'24
2
'25

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer